2289 — Charmacy Pharmaceutical Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$761.40m
- HK$1.10bn
- CNY4.44bn
- 40
- 88
- 38
- 58
Annual cashflow statement for Charmacy Pharmaceutical Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | CAS | CAS | CAS | CAS | CAS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 131 | -19.5 | 44.1 | -96.5 | 106 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 131 | -19.5 | 44.1 | -96.5 | 106 |
| Capital Expenditures | -52 | -25 | -8.59 | -40.8 | -15.7 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -2.8 | 0.638 | 80.4 | 80.2 | 0.085 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -54.8 | -24.4 | 71.8 | 39.3 | -15.6 |
| Financing Cash Flow Items | -68.1 | -63.1 | 53.8 | 27 | -270 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -2.68 | 74.4 | -191 | 101 | -31.5 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 73.6 | 30.5 | -75.4 | 44.1 | 58.9 |